MedTrace Logo

Xience/Promus for Long Coronary Lesion Registry

NCT01147237 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2010-06-22

No results posted yet for this study

Summary

The utilization of everolimus-eluting coronary stents in a coronary artery diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To evaluate the procedural, short and long term clinical outcomes of multiple everolimus-eluting coronary stent implantation in long (\>30mm) coronary lesions.

Conditions

  • Long Coronary Artery Disease

Interventions

DEVICE

Intracoronary stent implantation

Everolimus-eluting stent implantation in patients with long coronary artery disease

Sponsors & Collaborators

  • Society for Advancement of Coronary Intervention Research

    lead NETWORK

Principal Investigators

  • Yuji Oikawa, MD, PhD · Cardiovascular institute hospital

  • Kenya Nasu, MD · Toyohashi Heart Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-09-30
Completion
2012-12-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01147237 on ClinicalTrials.gov